IFNA2 and systemic lupus erythematosus: These findings lead us to the hypothesis that pivotal immunopathogenic disease drivers in SLE, such as IFN-α, and the overall SLE inflammatory activity may drive the accelerated neuronal damage observed in SLE patients, with or without NPSLE, ultimately leading to MRI alterations and cognitive dysfunction.